NCT02885090

Brief Summary

Rett syndrome (RTT) is a genetic encephalopathy and the typical form is caused by mutations in the gene MECP2. It is a genetically heterogeneous pathology. CDKL5 and FOXG1 have been recently discovered being involved in other forms of RTT. However, at least 5% of typical forms and more other atypical forms are not linked to any of 3 genes known to be involved in the disease. The purpose of this study is to identify new genes involved in molecular etiology of typical and atypical forms of RTT.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2010

Geographic Reach
1 country

9 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2010

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2011

Completed
5.3 years until next milestone

First Submitted

Initial submission to the registry

August 23, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 31, 2016

Completed
Last Updated

August 31, 2016

Status Verified

August 1, 2016

Enrollment Period

1.2 years

First QC Date

August 23, 2016

Last Update Submit

August 26, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Analysis of chromosomal imbalances through comparative genomic hybridization on DNA microarrays

    Search for pathogenic chromosomal imbalance

    up to 12 months

Study Arms (2)

RTT patient

EXPERIMENTAL

Blood sampling

Procedure: Blood sampling

Parents

EXPERIMENTAL

Blood sampling. To distinguish between inherited polymorphic variants and potentially deleterious new imbalances.

Procedure: Blood sampling

Interventions

In children: 2 EDTA tubes of 7 ml, 1 Heparin Li tube of 5 ml and 2 PAXgene tubes of 2.5 ml (max 0.8-0.9 ml blood/kg) In parents: 2 EDTA tubes of 7 ml, 1 Heparin Li tube of 5 ml.

ParentsRTT patient

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients: RETT syndrome
  • Patients: Female
  • Parents: parent of a patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

Handicaps de l'Enfant - Pavillon Ste Marie, CHU St Jacques

Besançon, France

Location

Service de Neuropédiatrie, Hôpital St Jacques, CHU de Besançon

Besançon, France

Location

Unité de génétique, Groupe hospitalier Hôpital Flaubert

Caen, France

Location

Centre de Génétique Hôpital d'Enfants, CHU de Dijon

Dijon, France

Location

Service de neuropédiatrie, CHU Hôpital Gui de Chauliac

Montpellier, France

Location

Laboratoire de Génétique chromosomique, CHU Hôpital l'Archet 2

Nice, France

Location

Service de génétique médicale, CHU Hôpital Purpan

Nice, France

Location

Service de génétique médicale, CHU Hôpital Purpan, CHU de Toulouse

Toulouse, France

Location

Laboratoire de Génétique, Hôpitaux de Brabois, CHU de Nancy

Vandœuvre-lès-Nancy, France

Location

MeSH Terms

Conditions

Rett Syndrome

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

X-Linked Intellectual DisabilityIntellectual DisabilityNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesGenetic Diseases, X-LinkedGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesHeredodegenerative Disorders, Nervous System

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Christophe PHILIPPE,

    Laboratoire de Génétique Médicale, Rue du Morvan, 54511 Vandoeuvre-Les-Nancy Cédex

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 23, 2016

First Posted

August 31, 2016

Study Start

February 1, 2010

Primary Completion

May 1, 2011

Study Completion

May 1, 2011

Last Updated

August 31, 2016

Record last verified: 2016-08

Data Sharing

IPD Sharing
Will not share

Locations